Specialist Childhood Posttraumatic Stress Disorder (PTSD) Treatment Trials

Specialist Childhood Posttraumatic Stress Disorder (PTSD) Treatment Trials


The Childhood PTSD treatment stream is coordinated by Dr Richard Meiser-Stedman, and addresses the need for the development of acceptable, feasible and efficacious treatments for childhood posttraumatic stress. C2:AD currently supports two exploratory RCTs; PYCES and DECRYPT investigating our protocol of trauma-focused cognitive behavioural therapy – the Triple M model (CBT-3M) – in the treatment of childhood and adolescent PTSD.


PYCESPYCES stands for Parents and Young Children Under Extreme Stress and compares usual care against our CBT-3M protocol adapted for younger children aged 3-8 years old who have experienced or witnessed an extreme event and have developed PTSD following the event. Recruitment for this study is continuing until October 2017.

decrypt-02 (jpg) med drastically cropped (2)

DECRYPT stands for Delivery of Cognitive therapy for Young People after Trauma and builds on PROSPECTS (see previous studies section). It is comparing usual care with out extended and modified version of CBT-3M for the treatment for PTSD in children and adolescents who have experienced multiple, repeated traumatic stressors, such as abuse or domestic/community violence. This project is running at multiple sites in the UK.


For more information please email: decrypt@uea.ac.uk

Forvie Site, Addenbrooke's Hospital, Hills Road, CB2 0QQ

Tel:01223 355294
DL:01223 273779

Cookies and Privacy